FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

The purpose of the FDA (R13) Scientific Conference Grant Program is to facilitate the provision of federal financial assistance in support of high-quality conferences and scientific meetings designed to research and investigate a topic clearly aligned with the FDA mission. The FDA recognizes the value of supporting high quality conferences and scientific meetings relevant to its mission and to the public health. A conference or scientific meeting is defined as a symposium, seminar, workshop, or any formal meeting, whether conducted face-to-face or virtually to exchange information and explore a defined subject, issue, or area of concern impacting the public's health within the scope of the FDA's mission. Permission to submit a conference grant application does not assure funding or funding at the level requested. FDA will not issue a conference grant award unless it can be issued before the conference start date.  

Deadlines:

April 12, 2023 and October 12, 2023

April 12, 2024 and October 11, 2024

April 11, 2025 and October 10, 2025 

PAR-23-072 Expiration Date October 11, 2025

Eligibility

Faculty

Category

Curriculum Development
Medical
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

April 12, 2024